Co-GP / Platform:A family office could deploy into the Boston life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from their expertise.

Co-GP / Platform:A family office could deploy into the Puget Sound life sciences market by backing a sponsor or operator at the GP level, focusing on co-GP or JV equity structures to leverage their expertise.

Co-GP / Platform:A family office could deploy into the Bay Area life sciences market by backing a sponsor or operator at the GP level, sharing in the promote and accessing a pipeline of development projects.

Co-GP / Platform:A family office could deploy into the San Diego life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from their expertise.

Co-GP / Platform:A family office could deploy into the Raleigh life sciences market by backing a sponsor or operator at the GP level, focusing on co-GP or JV equity to capitalize on growth.

Co-GP / Platform:A family office could deploy into the Seattle life sciences market by backing a sponsor or operator at the GP level, sharing in the promote and benefiting from the sector's growth.

Co-GP / Platform:A family office could deploy into the life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from a repeatable pipeline.

Co-GP / Platform:A family office could deploy into the Philadelphia life sciences market by backing a sponsor or operator at the GP level to share in the promote and access a repeatable deal flow.

Co-GP / Platform:A family office could deploy into this market by backing a life sciences operator at the GP level, sharing in the promote and benefiting from their established networks.

Co-GP / Platform:A family office could deploy into this market by backing a local life sciences operator at the GP level to share in the promote and benefit from their established networks.

Co-GP / Platform:A family office could deploy into the Denver life sciences market by backing a sponsor or operator at the GP level to share in the promote and access a repeatable pipeline.

Co-GP / Platform:A family office could deploy into this market by backing a leading life sciences operator at the GP level to share in the promote and benefit from their established pipeline.

Co-GP / Platform:A family office could deploy into the Washington D.C. life sciences market by backing a sponsor or operator at the GP level to capitalize on the growing investment activity.

Co-GP / Platform:A family office could deploy into this market by backing a life sciences operator at the GP level, sharing in the promote and benefiting from their expertise.

Co-GP / Platform:A family office could deploy into the Boston life sciences market by backing a sponsor or operator at the GP level, sharing in the promote and benefiting from a robust deal flow.

Co-GP / Platform:A family office could deploy into the Life Sciences market by backing a sponsor or operator at the GP level, sharing in the promote and benefiting from a repeatable investment pipeline.

Co-GP / Platform:A family office could deploy into the Denver life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from a strong pipeline of projects.

Co-GP / Platform:A family office could deploy into the Bay Area life science market by backing a specialized operator at the GP level, engaging in co-GP or JV equity arrangements to share in the promote.

Co-GP / Platform:A family office could deploy into the Boston life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from their expertise.

Co-GP / Platform:A family office could deploy into the Boston life science market by backing a sponsor or operator at the GP level to share in the promote and benefit from their expertise.

Co-GP / Platform:A family office could deploy into the Bay Area life sciences market by backing a sponsor or operator at the GP level to share in the promote and access a robust pipeline.

Co-GP / Platform:A family office could deploy into the life sciences market by partnering with established operators as a co-GP, sharing in the promote and benefiting from a robust pipeline of opportunities.

Co-GP / Platform:A family office could deploy into the life sciences market by backing a sponsor with a robust portfolio of lab projects, sharing in the promote and enterprise value.

Co-GP / Platform:A family office could deploy into the Raleigh life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from a repeatable pipeline.